Only four percent of the Covid-19 patients showed signs of a ‘cytokine storm’, with extremely high levels of immune molecules, says a study.

Researchers at Washington University School of Medicine in St. Louis have found in a preliminary study that the drug fluvoxamine seems to prevent some of the most serious complications of COVID-19 patients and make hospitalization and the need for supplemental oxygen less likely.

A study by researchers at Washington University School of Medicine in St. Louis suggests the eye's cornea can resist infection from the novel coronavirus.

Weight loss, whether from surgery or diet, has some metabolic benefits, according to a study from Washington University School of Medicine in St. Louis.